Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma
(Q37299181)
scientific article published on 29 July 2009
scientific article published on 29 July 2009
Language:
Current Data About
Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma
other details
| description | scientific article published on 29 July 2009 |
External Links
| (P356) |
10.1186/1479-5876-7-68
|
| (P698) |
19640287
|
| (P932) |
2724499
|
| (P5875) |
26703088
|
| (P6179) |
1048534051
|